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ABSTRACT: A catalytic, enzyme-initiated (aza-) Achmatowicz reaction is presented.
The involvement of a robust vanadium-dependent peroxidase from Curvularia
inaequalis allows the simple use of H2O2 and catalytic amounts of bromide.
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The Achmatowicz reaction1 over the years has demon-strated its usefulness in the conversion of furan rings into
heterocyclic scaﬀolds containing multiple functional handles for
further synthetic transformations. Key in the Achmatowicz
process is an oxidative activation of the furan ring, giving rise to
a reactive dicarbonyl intermediate, which cyclizes to give the
corresponding pyranone (X = O)2,3 or piperidinone (X = N-
EWG) structure (Scheme 1).4
Despite frequent application of the Achmatowicz protocol in
the synthesis of pharmaceutically relevant building blocks5−7
and natural products,8 the oxidative rearrangement is usually
conducted using stoichiometric amounts of an oxidative reagent
such as m-CPBA, and catalytic methods are scarce.
Recently, however, Deska and co-workers reported an
enzymatic version of the Achmatowicz reaction using the
well-known chloroperoxidase from Caldariomyces f umago
(CfCPO).9 One of the major challenges using CfCPO (as
with any heme-dependent enzyme) is its poor resistance against
the oxidant H2O2. Though this challenge can be met by in situ
generation of H2O2,
10−13 the resulting reaction schemes are
more complex than necessary.14
Furthermore, most in situ H2O2 generation methods yield
additional byproducts such as gluconic acid that not only
negatively inﬂuences the atom economy of the overall reaction
but also may complicate the reaction scheme. In addition, the
chemoenzymatic process seems restricted to Achmatowicz
reactions, while the corresponding aza-Achmatowicz products
are synthetically equally relevant. Therefore, we decided to
follow up on the seminal contribution by Deska using the
vanadium-dependent peroxidase from Curvularia inaequalis
[CiVCPO (Scheme 2)].15−20
The major advantage of CiVCPO over CfCPO lies in the
prosthetic group used (vanadate as compared to heme iron)
and the resulting high robustness of the peroxidase in the
presence of H2O2.
16 Essentially, this renders any in situ H2O2
generation redundant and allows for simple and clean (yielding
H2O as the sole byproduct) reaction schemes.
Pleasingly, already in initial aza-Achmatowicz experiments
under arbitrarily chosen reaction conditions, full conversion of
1a was observed within 24 h. It is worth noting here that in the
absence of either of the catalysts (CiVCPO or Br−) or the
oxidant (H2O2), no signiﬁcant conversion was observed.
Encouraged by these promising results, we set out to
determine the parameters inﬂuencing the eﬃciency of the
chemoenzymatic aza-Achmatowicz reaction. Acidic pH values
appeared to be necessary to achieve full conversion (Figure 1).
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Scheme 1. Achmatowicz Reactiona
aX = O for the Achmatowicz reaction, and X = N-EWG for the aza-
Achmatowicz reaction.
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This observation is in line with the previously determined
preference of CiVCPO for slightly acidic pH values.15−20
To ensure the high catalytic eﬃciency of CiVCPO while
minimizing the acidolytic degradation of the reagents, we
performed all subsequent reactions at pH 5.
Next we turned our attention to the inﬂuence of the catalysts.
Obviously, reducing the concentration of the biocatalyst
(CiVCPO) is desirable, but substoichiometric amounts of
bromide would avoid possible inhibitory eﬀects on the
enzyme.21,22 Pleasingly, both catalyst concentrations could be
reduced very signiﬁcantly without impairing the apparent
activity of the overall chemoenzymatic aza-Achmatowicz
reaction (Figures 2 and 3).
Reducing the biocatalyst concentration from 0.1 to 0.01 μM
resulted in a somewhat reduced reaction rate (Figure 2),
indicating that below 0.05 μM the enzymatic oxidation of Br−
becomes overall rate-limiting.
As shown in Figure 3, a decrease in the bromide
concentration from 10 mM to 50 μM (1 mol %) had no
apparent inﬂuence on the conversion of 1a into 2a. The
corresponding Achmatowicz reaction of alcohol 1d, however,
exhibited a very distinct dependency on the bromide
concentration applied (Figure 3, dark blue bars). Within the
time frame of these experiments, full conversion of the starting
material (1d) into product (2d) was observed only in the
presence of (super)stoichiometric amounts of KBr. One
possible explanation for this observation may be a low reactivity
of 1d with OBr−. The accumulating OBr− reacts with hydrogen
peroxide, giving rise to the formation of singlet oxygen,16
therefore necessitating higher in situ concentrations of the
latter. Nevertheless, catalytic amounts of bromide were feasible.
Encouraged especially by the high eﬃciency of the
chemoenzymatic aza-Achmatowicz reaction in the presence of
low bromide concentrations, we also evaluated seawater as a
reaction medium and source of bromide (Figure 4). The overall
rate of the chemoenzymatic aza-Achmatowicz reaction fell
signiﬁcantly behind the rate in deﬁned buﬀers. Instead of being
complete within maximally 30 min, full conversion was
achieved only within approximately 2.5 h (Figure 4).
Most probably, the reduced reaction rate can be attributed to
the huge molar surplus of chloride (∼550 mM) over bromide
(<1 mM) present in seawater, leading to a predominant
Scheme 2. Simpliﬁed Reaction Scheme for the CiVCPO-
Mediated (aza-)Achmatowicz Reactiona
aIn situ-formed, freely diﬀusible hypohalogenites (OBr− and OCl−)
presumably account for the (aza-)Achmatowicz conversion of starting
materials 1a−d. Abbreviations: Boc, tert-butyloxycarbonyl; Cbz,
carboxybenzyl.
Figure 1. Inﬂuence of pH on the chemoenzymatic aza-Achmatowicz
reaction: blue for c(1a) and red for c(2a). General conditions: solvent,
ethanol with 100 mM universal B&R (Britton−Robinson) buﬀer [1:1
(v/v)]; c(1) = 5 mM substrate; c(KBr) = 10 mM; c(H2O2) = 10 mM;
c(CiVCPO) = 0.1 μM (52 units mL−1); T = 30 °C; t = 24 h.
Figure 2. Inﬂuence of c(CiVCPO) on the chemoenzymatic aza-
Achmatowicz reaction: blue for c(1a) and red for c(2a). General
conditions: solvent, ethanol with 0.1 M citrate at pH 5 [1:1 (v/v)];
c(1) = 5 mM; c(H2O2) = 10 mM; c(KBr) = 0.05 μM; T = 30 °C; t =
24 h.
Figure 3. Inﬂuence of c(KBr) on the chemoenzymatic Achmatowicz
(dark blue) and aza-Achmatowicz (light blue) reactions. General
conditions: solvent, ethanol with 100 mM citrate buﬀer at pH 5 [1:1
(v/v)]; c(1a or 1d) = 5 mM substrate; c(H2O2) = 10 mM;
c(CiVCPO) = 0.1 μM (52 units mL−1); T = 30 °C; t = 24 h.
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formation of hypochlorite over hypobromite. Indeed, control
experiments in deﬁned buﬀers and KCl as halogen resulted in
only 46% conversion after 24 h under otherwise identical
conditions. Alternatively, substrate inihibition of CiVCPO by
chloride may also contribute to the reduced overall activity
observed in seawater.21 Further experiments clarifying the
chemical reactivities are currently ongoing in our laboratories.
Nevertheless, the experiments mentioned above suggest that
simple (and cheap) seawater may serve as the reaction medium
and source of catalysts for chemoenzymatic aza-Achmatowicz
reactions.
Admittedly, the characterization experiments reported above
are not suitable for preparative-scale application of the
proposed biocatalytic (aza-)Achmatowicz reaction. Therefore,
we set out to perform reactions at more practical reagent
concentrations [100 mM, approximately 25 g L−1 (Figure 5)].
Starting material 1a was converted smoothly into 2a within 4
h, corresponding to an excellent average turnover frequency of
CiVCPO of 8.7 s−1 over the entire reaction time. This
corresponds to an average speciﬁc activity of 7.8 units mg−1
(over at least 3 h), which is in good agreement with the speciﬁc
activity determined previously for this enzyme under initial rate
conditions (<30 s).21 This underlines the high robustness of
CiVCPO under operational conditions. The tunover number
for CiVCPO in this experiment exceeded 1 million, which
should be seen as a minimal value and not as a total turnover
number as the reaction proceeded in an almost linear fashion to
full conversion [Figure 5 (□)]. In contrast, the accumulation of
2d (oxo-Achmatowicz reaction) was somewhat slower and
yielded less product. It is also worth mentioning that after
approximately 3 h product accumulation ceased and formation
of a (yet undeﬁned) side product was observed via high-
performance liquid chromatography (HPLC) (see the Support-
ing Information for further information). Table 1 summarizes
the semipreparative conversions of starting materials 1a−d.
The aza-Achmatowicz reactions prodeeded smoothly to full
conversion of the starting materials into the target products
with only trace amounts of byproducts formed (see the
Supporting Information for further details), which were
removed by a single ﬂash chromatography step. Hence, the
moderate isolated yields listed in Table 1 can be assigned to a
suboptimal reaction workup and product isolation, which will
be further optimized in our laboratories. It should also be
mentioned that so far we have no indication of racemization of
the chiral center (“furanylic C−H bond”) in the course of the
reaction. Deska et al.9 found no racemization under comparable
conditions.
In summary, we have presented a chemoenzymatic
alternative to the established stoichiometric (aza-)Achmatowicz
protocols. CiVCPO is an eﬃcient catalyst for generating
hypohalogenites in situ under mild reaction conditions from
catalytic amounts of halogenides. Because of its high robustness
and catalytic activity, excellent turnover numbers and
frequencies have been observed, making it a promising catalyst.
Next to broadening the scope of the proposed chemoenzymatic
protocol, we will particularly focus on mechanistic studies and
investigation of the stereochemical outcome.
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Figure 4. Time courses of the chemoenzymatic aza-Achmatowicz
reaction using seawater (▲) and 50 μM KBr (□) as the halide source.
General conditions: ethanol with aqueous medium [0.1 M citrate (pH
5) and 0.05 mM KBr] or seawater [0.1 M citrate (pH 5), 1:0.74 (v/
v)]; c(1) = 5 mM; c(H2O2) = 10 mM; c(CiVCPO) = 0.1 μM (52 units
mL−1); T = 30 °C.
Figure 5. Representative time courses for the (aza-)Achmatowicz
reactions of 1a (□) and 1d (▲) at semiprepatative scale. General
conditions: solvent, ethanol with 100 mM citrate buﬀer at pH 5 [1:1
(v/v)]; c(1a or 1d) = 100 mM substrate; H2O2 added at 30 min
intervals in 10 mMfinal portions; c(CiVCPO) = 0.1 μM (52 units
mL−1); c(KBr) = 0.1 mM (1a) or 10 mM (1d); T = 30 °C; t = 24 h.
For the sake of clarity, the corresponding starting material
concentrations have been omitted; the mass balances in each reaction
were closed.
Table 1. Summary of Semipreparative-Scale Reactionsa
product conversion (%)b isolated producta diastereomeric ratio
2a 100 228 mg (69%) −
2b 100 160 mg (56%) 65:35
2c 100 175 mg (50%) 80:20
2d 100 195 mg (82%) 75:25
aSee the Supporting Information for further details about the reaction
conditions and product isolation and puriﬁcation. bDetermined via
HPLC.
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